AROC — AroCell AB (publ) Income Statement
0.000.00%
Last trade - 00:00
- SEK89.15m
- SEK38.43m
- SEK43.04m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.443 | 0.084 | 12 | 37 | 43 |
Cost of Revenue | |||||
Gross Profit | 0.071 | 0.063 | -5.04 | -2.1 | -2.1 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 21.2 | 24.1 | 62.6 | 96.3 | 103 |
Operating Profit | -20.7 | -24.1 | -50.6 | -59.3 | -59.8 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -20.7 | -24.1 | -50.6 | -59.3 | -59.3 |
Net Income After Taxes | -20.7 | -24.1 | -50.6 | -59.3 | -59.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -20.7 | -24.1 | -50 | -59 | -59.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -20.7 | -24.1 | -50 | -59 | -59.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.526 | -0.327 | -0.32 | -0.09 | -0.086 |
Dividends per Share |